Table 1.
Pathological types | Cell lines | PD‐L1 expression before IFN‐γ coculture (%) | PD‐L1 expression after IFN‐γ coculture (%) | After‐before |
---|---|---|---|---|
AC | A2 | 1.91 | 51.60 | 49.69 |
AC | A549 | 0.29 | 44.60 | 44.31 |
AC | NCI‐H2009 | 22.30 | 77.60 | 54.70 |
AC | HCC‐827 | 40.00 | 93.00 | 53.00 |
AC | CALU‐1 | 0.41 | 54.50 | 54.09 |
SC | NCI‐H2170 | 18.10 | 3.40 | −14.70 |
SC | NCI‐H1703 | 2.15 | 31.80 | 29.65 |
LCC | PLA‐801D | 1.03 | 34.50 | 33.47 |
LCC | NCI‐H661 | 1.10 | 24.00 | 22.90 |
LCC | NCI‐H460 | 1.20 | 55.90 | 54.70 |
SCC | NCI‐H209 | 3.04 | 11.30 | 8.26 |
SCC | NCI‐H69 | 0.90 | 7.80 | 6.90 |
SCC | NCI‐H446 | 0.73 | 43.00 | 42.27 |
AC, adenocarcinoma; LCC, large cell carcinoma; SCC, small cell carcinoma; SC, squamous cell carcinoma.